Thursday, April 18, 2024
Blogger Facebook Linkedin Pinterest Twitter

Tag: Phase 3 study

Lupin

Lupin announces results of phase 3 study of Single-Dose Solosec for...

HTP Desk - 0
Lupin Pharmaceuticals announced positive top-line results from its pivotal Phase 3 clinical trial to assess efficacy and safety of single-dose Solosec (secnidazole) 2g oral...
Healthtekpak delivers daily news, updates, analysis, case studies and industry scoops related to the health industry.
Contact us: editor@ippgroup.in
Blogger Facebook Linkedin Pinterest Twitter
© 2020. All content (text and/or media) is intellectual property of IPP Catalog Publications Pvt. Ltd.

This function has been disabled for HealthTekPak.

error: Content is protected !!